FedEx Bolsters Global Healthcare Supply Chain Capabilities

FedEx has launched FedEx Life Sciences, a specialist division supporting the transportation of pharmaceuticals, medical devices, biologics, clinical trial materials and other critical healthcare shipments.

The new division will combine FedEx's global logistics network with specialist healthcare expertise and advanced monitoring capabilities to support pharmaceutical and healthcare stakeholders worldwide.

FedEx’s global healthcare revenues have already grown to approximately US$10bn, indicating healthcare’s prominent position within existing business operations.

As medicines become more specialised and globally distributed, healthcare companies need specialist logistics networks built for precision, visibility and reliability. 

FedEx joins other major logistics organisations, including UPS, DHL and Kuehne+Nagel, in establishing a dedicated healthcare business as demand grows for specialist logistics capable of handling the specific demands of medical transportation.

FedEx’s growing healthcare focus

FedEx Life Sciences builds on the company's significant investments into its healthcare infrastructure and technological capabilities.

In 2025, the company attained IATA CEIV Pharma Corporate Certification, validating its compliance with rigorous standards for the ground handling of pharmaceutical products across its global air hubs and ramp operations.

FedEx’s healthcare and life sciences teams have also expanded in recent years, while six strategically located Life Sciences Centers have been established in the US, the Netherlands, India, South Korea, Singapore and Japan.

These hubs deliver tailored solutions for the healthcare industry, including kitting, storage and fulfillment, maintaining strict thermal environments from cryogenic conditions to ambient temperatures.

Meeting the unique demands of healthcare logistics

The highly specialised nature of healthcare logistics was a leading motivation behind the formation of FedEx’s dedicated life sciences organisation. 

A fragmented regulatory landscape, highly specialised transportation conditions and urgent patient requirements all ensure healthcare poses a unique challenge to logistics operators.

“Transporting vital healthcare deliveries requires more than just standard logistics. It depends upon an intelligent, highly specialised network built for patient-critical needs,” says Brie Carere, Executive Vice President and Chief Customer Officer at FedEx.  

“Every shipment we move in this space has the potential to support a researcher, a medical professional, or most importantly, a patient waiting for care. 

“To meet these critical demands, FedEx Life Sciences brings together our global network, advanced monitoring and specialised expertise to make supply chains smarter and more resilient.”  

In addition to the technical specificities, healthcare supply chains are also vulnerable to geopolitical shocks, such as ongoing conflicts in the Middle East that have disrupted sectors across the industrial spectrum.

Experienced leadership team

FedEx Life Sciences will be led by the deeply experienced Nick Gennari, who joined FedEx in 1992.

Nick spent much of his tenure advancing commercial strategy and logistical frameworks for international medical, aviation and advanced technology partners, before taking the helm of FedEx’s healthcare department in 2024.

“Healthcare supply chains are becoming more complex, and the stakes are deeply personal,” says Nick.

“FedEx Life Sciences gives our customers a more focused team, stronger coordination, and specialised expertise to help them move critical healthcare shipments with confidence. Our role is to provide the certainty, visibility, and global reach healthcare innovators need when every shipment matters.”